Today: 30 April 2026
Bradesco stock price hovers near a 52-week high as Brazil rate decision nears, earnings next week
28 January 2026
2 mins read

Bradesco stock price hovers near a 52-week high as Brazil rate decision nears, earnings next week

New York, Jan 28, 2026, 11:23 (ET) — Regular session

  • Banco Bradesco’s shares on the U.S. market nudged up 0.1% in early trading, hovering close to their recent peaks
  • Brazil’s central bank is set to announce its policy decision Wednesday, following inflation figures that reached the upper limit of the target range
  • Bradesco will release its fourth-quarter results on Feb. 5, followed by a call scheduled for Feb. 6

Shares of Banco Bradesco S.A. listed in the U.S. edged up Wednesday, staying near a 52-week high. Investors held back ahead of Brazil’s interest-rate announcement scheduled for later and digested a flurry of company updates ahead of next week’s earnings.

This matters now because of rates. Brazilian banks often react to the Selic, the country’s key benchmark rate, since it influences loan demand, funding costs, and credit stress on household balance sheets.

This week’s focus centers on inflation figures and the central bank’s Copom policy committee kicking off its 2026 decisions. Traders are betting on a pause now, with rate cuts on the horizon. That uncertainty has left bank stocks jittery, despite a slow corporate news flow.

Bradesco’s ADRs changed hands at $4.145, edging up roughly 0.1%, following an earlier range between $4.135 and $4.20.

Shares of Brazil-linked financial rivals saw gains: Itaú Unibanco’s U.S.-listed stock climbed roughly 1.5%, Santander Brasil’s ADRs gained about 0.4%, and Nubank’s Nu Holdings moved slightly higher.

Brazil’s IPCA-15 inflation index, a key early gauge of official inflation, ticked up 0.20% in January. That lifted the annual rate to 4.50%, right at the top end of the central bank’s target band. The Copom meeting on Wednesday is widely expected to hold rates steady. Still, investors are eager for hints on whether rate cuts might begin as soon as March.

William Jackson, chief emerging markets economist at Capital Economics, said the 4.5% figure will probably “remove any lingering expectations” of a rate cut at this meeting, though he still anticipates easing to begin in March. Capital Economics

This week on Latibex in Madrid, Bradesco revised its tax rate and per-share net values for the monthly “interest on shareholders’ equity” — a Brazilian cash distribution akin to dividends — but left its payment timetable intact. latibex.com

The lender also announced its next annual general meeting is set for March 10.

Bradesco announced it has renewed its agreement with payments company Cielo. The deal, labeled a related-party transaction, involves services aimed at attracting and retaining merchants for possible accreditation within the Cielo system.

Bradesco bulls face a clear risk: should Copom take a hawkish turn beyond what investors anticipate—or if inflation picks up again—expect rate-cut bets to unravel quickly, dragging bank shares lower. Signs of rising provisions or deteriorating credit quality in Bradesco’s upcoming results would only intensify this pressure.

Attention is now on Wednesday’s central bank decision and Bradesco’s Q4 report, set for Feb. 5 after markets close in Brazil and New York. The bank will hold a management videoconference the next morning, Feb. 6, at 8:30 a.m. ET.

Stock Market Today

  • KalVista Pharmaceuticals Rises 39% on Acquisition Deal with Chiesi Group
    April 29, 2026, 6:37 PM EDT. KalVista Pharmaceuticals surged 38.62% to $26.67 after announcing its acquisition by Italy's Chiesi Group at $27 per share in cash. The deal sparked high trading volume, reaching 69.4 million shares, over 3,000% above average. KalVista, known for its oral therapy EKTERLY for hereditary angioedema, could benefit from Chiesi's global reach. The broader market was mixed: the S&P 500 dipped 0.02% to 7,138, while the Nasdaq edged up 0.04% to 24,673. Rival biotech stock Prothena dropped 5.56% amid investor caution over drug pipelines. KalVista's acquisition marks a shift for a company that faced heavy short interest and revenue challenges, positioning it for growth under Chiesi's ownership, pending regulatory approval.

Latest article

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

Brookfield Renewable Stock Drops 12% Before Q1 Results as BEPC Investors Brace for Friday

30 April 2026
Brookfield Renewable Corp’s NYSE shares fell 12.5% to $35.20 on Wednesday, with volume quadrupling the three-month average ahead of first-quarter results due Friday. The drop came despite a higher quarterly dividend and mixed analyst views. The company operates 47 GW of clean energy assets globally. Analysts expect a first-quarter loss of 33.92 cents per share on $1.62 billion in revenue.
Markel Stock Slides After $728 Million Investment Loss Masks Insurance Turnaround

Markel Stock Slides After $728 Million Investment Loss Masks Insurance Turnaround

30 April 2026
Markel Group posted a $212.3 million net loss for the first quarter, driven by a $728 million investment loss, sending shares down 7.9% to $1,759.21. Operating revenue held steady at $3.55 billion, while adjusted operating income rose 4% to $498 million. Markel Insurance’s adjusted operating income jumped 31% to $369 million. Gross premium volume in underwriting fell 21% after exiting Global Reinsurance.
QQQ Rises Today as Big Tech Earnings Put the Nasdaq 100 Rally on the Line

QQQ Rises Today as Big Tech Earnings Put the Nasdaq 100 Rally on the Line

30 April 2026
The Invesco QQQ Trust closed up $3.99 at $661.57 Wednesday as investors positioned ahead of earnings from Microsoft, Alphabet, Amazon, and Meta. Volume topped 30 million shares. Microsoft and Alphabet reported strong cloud and AI-driven revenue growth after the bell. The broader Nasdaq Composite edged up 0.04%, while the S&P 500 slipped 0.04%.
CoreWeave stock slips in New York as Nvidia deal digested; CRWV traders eye next earnings
Previous Story

CoreWeave stock slips in New York as Nvidia deal digested; CRWV traders eye next earnings

B2Gold stock pops as gold hits record above $5,300 — what BTG traders watch next
Next Story

B2Gold stock pops as gold hits record above $5,300 — what BTG traders watch next

Go toTop